These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9042268)

  • 1. The dual role of mutant p53 protein in chemosensitivity of human cancers.
    Mueller H; Eppenberger U
    Anticancer Res; 1996; 16(6B):3845-8. PubMed ID: 9042268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL; Ling YF; Lai MD
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
    Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM
    Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 and response to chemotherapy and radiotherapy.
    Ruley HE
    Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
    Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
    Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 regulation and function in normal cells and tumors.
    Liu Y; Kulesz-Martin M
    Medicina (B Aires); 2000; 60 Suppl 2():9-11. PubMed ID: 11188940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
    Wu GS; Ding Z
    Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [P53 mutations, asset or disadvantage for cancer chemotherapy].
    Jacquemin-Sablon A
    Bull Cancer; 1997 Jul; 84(7):741-6. PubMed ID: 9339201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antioncogene p53 and apoptosis response: new hypotheses on the molecular bases of tumor resistance to radiotherapy].
    Corvò R
    Radiol Med; 1996 Sep; 92(3):298-302. PubMed ID: 8975319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2.
    Wu GS; El-Deiry WS
    Clin Cancer Res; 1996 Apr; 2(4):623-33. PubMed ID: 9816212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of p53 in death of IL-3-dependent cells in response to cytotoxic drugs.
    Palacios C; Gutierrez del Arroyo A; Silva A; Collins MK
    Oncogene; 2000 Jul; 19(31):3556-9. PubMed ID: 10918614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.
    Geley S; Hartmann BL; Hattmannstorfer R; Löffler M; Ausserlechner MJ; Bernhard D; Sgonc R; Strasser-Wozak EM; Ebner M; Auer B; Kofler R
    Oncogene; 1997 Nov; 15(20):2429-37. PubMed ID: 9395239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
    Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
    Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the Jun kinase pathway blocks DNA repair, enhances p53-mediated apoptosis and promotes gene amplification.
    Gjerset RA; Lebedeva S; Haghighi A; Turla ST; Mercola D
    Cell Growth Differ; 1999 Aug; 10(8):545-54. PubMed ID: 10470854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
    Wiman KG
    Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting p53 for enhanced radio- and chemo-sensitivity.
    Lu C; El-Deiry WS
    Apoptosis; 2009 Apr; 14(4):597-606. PubMed ID: 19259822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of p53-mediated apoptosis and recovery of chemosensitivity through p53 transduction in human glioblastoma cells by cisplatin.
    Park CM; Park MJ; Kwak HJ; Moon SI; Yoo DH; Lee HC; Park IC; Rhee CH; Hong SI
    Int J Oncol; 2006 Jan; 28(1):119-25. PubMed ID: 16327987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K; Li Z; Seth P; Cowan KH; Sinha BK
    Oncol Res; 1997; 9(11-12):603-9. PubMed ID: 9563008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cells.
    Yang B; Eshleman JR; Berger NA; Markowitz SD
    Clin Cancer Res; 1996 Oct; 2(10):1649-57. PubMed ID: 9816112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 dependence and apoptosis in response to FP treatment with p53-transfected colon cancer cell lines by use of thin layer collagen gel.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Oncol Rep; 2004 Aug; 12(2):357-61. PubMed ID: 15254702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.